Model Contracts for Innovative Oncology Therapies

Eric NormanFoCUS, Research Briefs

When there is substantial uncertainty about a new product’s expected value, stakeholders may have strong reasons to consider performance-based contracts. One of the hardest tasks in crafting such contracts is … Read More

FoCUS Design Lab

Eric Norman

Invitation-only Design Lab to further discussions/implementation from the April 2018 Design Lab

Role of COE networks in curative cellular oncology therapies

Eric NormanFoCUS, Research Briefs

COE networks currently play an important role in the delivery of care for specialized service lines, including but not limited to solid organ transplantation (SOT), hematopoietic cell transplantation (HCT) and … Read More

Designing financial solutions to ensure affordable access to cures

Eric NormanFoCUS, Whitepapers

The reimbursement of emerging durable/potentially curative cell and gene therapies is likely to be a challenge for the US healthcare market. Considering the pricing of cell- and gene-based therapies approved … Read More

Stop-Loss Insurance or Reinsurance for Multiyear Contracts

Eric NormanFoCUS, Research Briefs

In previous Research Briefs, we have discussed challenges faced by payers when contemplating using multiyear performance-based contracts. In this brief, we extend the discussion to include additional difficulties that may … Read More